SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-281012
Filing Date
2015-08-06
Accepted
2015-08-06 16:10:25
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d34679d10q.htm 10-Q 570568
2 EX-31.1 d34679dex311.htm EX-31.1 6027
3 EX-31.2 d34679dex312.htm EX-31.2 5863
4 EX-32.1 d34679dex321.htm EX-32.1 4199
  Complete submission text file 0001193125-15-281012.txt   2691140

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20150630.xml EX-101.INS 396994
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20150630.xsd EX-101.SCH 36009
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20150630_cal.xml EX-101.CAL 50238
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20150630_def.xml EX-101.DEF 105380
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20150630_lab.xml EX-101.LAB 265895
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20150630_pre.xml EX-101.PRE 191906
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 151033215
SIC: 2834 Pharmaceutical Preparations